At a glance
ClinicalIndex Comparison RecordN/ACompleted· 84 enrolled
Drug / intervention
Phasix™ Meshdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Post-Market, Prospective, Multi-Center, Single-Arm Clinical Investigation of Phasix™ Mesh for VHWG Grade 3 Midline Hernia Repair
In Brief
A clinical study evaluating Phasix™ Mesh for Hernia and 2 related conditions. Completed, enrolled 84 participants across 15 sites in 8 countries.
Detailed Summary
The purpose of this study is to collect additional data on safety and performance of Phasix™ Mesh in subjects requiring Ventral Hernia Working Group (VHWG) Grade 3 midline hernia repair.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHernia, Hernia, Abdominal, Hernia, Incisional
CountriesAustria, Belgium, Denmark, France, Germany, Italy, Netherlands, United Kingdom
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartMar 2016
First PostedMar 2016
Primary CompletionJul 2017
Study CompletionJun 2019
TodayJul 2026
First PostedMar 25, 2016
Enrollment StartMar 23, 2016
Primary CompletionJul 31, 2017
Study CompletionJun 20, 2019
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 10.3 years ago
Interventions
Phasix™ Meshdevice
A resorbable mesh prepared from poly-4-hydroxybutyrate (P4HB)